Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tianjin Weijie Pharmaceutical is a China-based pharmaceutical company specializing in the research, development, and large-scale manufacturing of Active Pharmaceutical Ingredients (APIs) and finished dosage forms. The company focuses primarily on therapeutic areas such as cardiovascular health, anti-infectives, and the central nervous system. With a strong emphasis on international quality standards, Weijie Pharmaceutical holds multiple certifications including Chinese GMP, US FDA, and EU CEP. Their product portfolio includes widely used medications like Rosuvastatin, Atorvastatin, and Clopidogrel. The company operates as both a generic drug manufacturer and a contract development and manufacturing organization (CDMO) for global partners.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tianjin Weijie Pharmaceutical.